Please note that masks are still required in all Blue Ridge Cancer Care offices regardless of vaccination status.
Learn more about this and other current Covid-19 policies.

Research Institute

Phase 2 Study of SBRT with GC4711 for Unresectable, Non-Metastatic Pancreatic Cancer

A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4711 in the Treatment of Unresectable or Borderline Resectable, Nonmetastatic Pancreatic Cancer

Disease Types: Pancreatic

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4711 in the Treatment of Unresectable or Borderline Resectable, Nonmetastatic Pancreatic Cancer

For more information:

https://clinicaltrials.gov/ct2/show/NCT04698915?term=A+Randomized%2C+Phase+2+Study+of+Stereotactic+Body+Radiation+Therapy+%28SBRT%29+in+combination+with+GC4711+in+the+Treatment+of+Unresectable+or+Borderline+Resectable%2C+Nonmetastatic+Pancreatic+Cancer&draw=2&rank=1